Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2007
11/29/2007US20070274981 Fibroblast Growth Factor Receptor-1 Inhibitors and Methods of Treatment Thereof
11/29/2007US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
11/29/2007DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/29/2007DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007CA2652838A1 Bilayer tablet for preventing cardiovascular events
11/29/2007CA2652675A1 Chondroitin sulfate degradation to ameliorate brain damage induced by hypoxia
11/29/2007CA2651420A1 Spiro tetracyclic compound
11/29/2007CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/28/2007EP1860180A1 Method for amplification of endothelial progenitor cell in vitro
11/28/2007EP1860114A1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator
11/28/2007EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007EP1859797A1 Novel concomitant use of sulfonamide compound with anti-cancer agent
11/28/2007EP1858867A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858853A2 Novel pyridine derivatives as potassium ion channel openers
11/28/2007EP1858849A1 Organic compounds
11/28/2007EP1858553A2 Methods of decreasing calcification
11/28/2007EP1858542A2 Compositions and methods for treating vascular permeability
11/28/2007EP1542710A4 Methods for preserving organs and tissues
11/28/2007EP1458395B1 Medical use of gsk3-inhibiting oxindole derivatives
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1399430B1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1302104B1 P300 transgenic animal
11/28/2007CN101080413A Silicon compounds and their use
11/28/2007CN101080406A Indazole-carboxamide compounds
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080232A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and hmg CoA reductase inhibitors
11/28/2007CN101080225A Combination therapy comprising telmisartan and hydrochlorothiazide
11/28/2007CN101078012A 干细胞分化 Stem cell differentiation
11/28/2007CN101077364A Traditional Chinese medicine composition for treating cardio cerebrovasculer disease and its preparations and preparation method
11/28/2007CN101077363A Traditional Chinese medicine composition for treating angina pectoris and and preparation method and application thereof
11/28/2007CN101077356A Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine and other medicines
11/28/2007CN101077353A Cardiac and cerebral vascular disease treating medicine
11/28/2007CN101077175A Three kinds of seed health care tea soup
11/28/2007CN101077156A Kudzu root whole soybean powder and its preparation method
11/28/2007CN101077109A Bananas yoghourt tea
11/28/2007CN101077108A Health-care tea and its preparing process
11/28/2007CN100351263C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100350979C Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
11/28/2007CN100350915C Medicine for treating metabolism syndrome
11/28/2007CN100350912C Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid
11/28/2007CN100350909C Method for preparing insoluble drug single-tablet-core single-chamber osmotic pump sustained-release preparations and its product
11/28/2007CN100350900C Diphase capsule of compound dalbergia wood and preparation method
11/28/2007CN100350899C Diphase capsule of red sage root for coronary heart disease and preparation method
11/28/2007CN100350898C Diphase capsule of compound notoginseng and preparation method
11/27/2007US7301067 Screening for peptides which when coated on stents and inserted into a human are useful for treating or preventing atherosclerosis or transplant arteriopathy or restenosis; identifying peptides that inhibit or cell proliferation or migration in vascular smooth muscle cells
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300765 SC6 for diagnosis of cancers
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/27/2007CA2271683C Coated particles, methods of making and using
11/27/2007CA2253613C Therapeutic treatment for vegf related occular diseases
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132906A1 Benzylamine derivatives as cetp inhibitors
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132888A1 Smooth muscle contraction inhibitor
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132825A1 Pharmaceutical agent
11/22/2007WO2007132718A1 Solid preparation comprising adenosine 5'-triphosphate or physiologically acceptable salt thereof
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007132179A2 Therapeutics comprising pyridinium derivatives
11/22/2007WO2007132054A1 New use of therapeutically useful peptides
11/22/2007WO2007131805A1 Use of drospirenone for preventing high blood pressure in prehypertensive patients
11/22/2007WO2007131446A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
11/22/2007WO2007131444A1 New crystallographic form of the compound 3,4',5-trihydroxyl-stilbene-3-beta-d-glucoside
11/22/2007WO2007117482A3 Renin inhibitors
11/22/2007WO2007112135A3 Methods and systems for treating injured cardiac tissue
11/22/2007WO2007093608A8 Drug combinations for the treatment of respiratory tract diseases
11/22/2007WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/22/2007WO2007087293A3 Mapc therapeutics without adjunctive immunosuppressive treatment
11/22/2007WO2007087292A3 Mapc treatment of brain injuries and diseases
11/22/2007WO2007078990A3 Modified lysine-mimetic compounds
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007WO2007027225A3 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/22/2007WO2006121719A3 Soluble epoxide hydrolase inhibitors and methods of using same
11/22/2007US20070270506 Novel human kinases and polynucleotides encoding the same, and uses thereof
11/22/2007US20070270490 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 1595